Skip to main content

New functionality and detector system was successfully exhibited at AAPM in Philadelphia

New functionality and detector system was successfully exhibited at AAPM in
C-RAD AB with its three fully owned subsidiaries are all active in the field of 
radiation therapy. The company attended and exhibited at the annual physicist   
meeting AAPM in Philadelphia, USA, 18-21 July. The GEMini and Sentinel systems  
were presented in the C-RAD booth. The Sentinel system was also exhibited in the
Elekta booth with the robotic couch Hexapod Evo.   
The annual physicist meeting AAPM in the US is one of the major events in       
radiation therapy.  The main focus for C-RAD this year was to introduce new     
software functionality for respiratory gating and to present the GEMini ED      
system. Both systems are FDA- pending. The meeting was a success. Compared to   
last year´s meeting number of leads doubled. Both the ROS representative and the
new C-RAD sales manager in the US were busy in demonstrating the unique features
of the Sentinel system. New orders for the Sentinel system were signed.    
This important meeting is also offering an opportunity to meet partners and     
representatives. Both technical and commercial discussions took place to        
integrate the C-RAD systems with the systems of the main vendors in radiation   

Erik Hedlund, CEO, C-RAD AB:                                                    

”USA represents almost 50% of the world market in radiation therapy. Success on 
this market has also a positive impact on sales in rest of the world. To        
penetrate this market, investment in marketing and sales will be further        

For further information:                                                        
Erik Hedlund, CEO C-RAD AB, Telephone: +46- 18 - 66 69 31, E-Mail:                                                                

About C-RAD AB                                                                  
C-RAD develops new and innovative solutions for the use in advanced radiation   
therapy. The company group of C-RAD offers products and solutions for patient   
positioning, tumor localization and radiation treatment systems. End users are  
radiation therapy clinics worldwide. All product development is conducted in    
three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD
Innovation AB. C-RAD Imaging AB is located in Östersund while the other         
companies are located in Uppsala. Numbers of employees are currently 19 people. 
The activities in C-RAD AB originate from research and development at the       
Karolinska Institute in Solna. Sales of the company's first product, the C-RAD  
Sentinel TM, started in 2007. Cooperation agreements have been signed with the  
Swedish company Elekta and the Belgian company IBA. C-RAD is represented by     
distributors specialized in radiation therapy on major markets. C-RAD AB is     
since March 2010 listed at Nasdaq Omx First North Premier.
Close Menu